Consumer Nation
Katie Little
More
-
In the next 14 months, patents for the top 20 drugs in the U.S. are set to expire. Although makers of such top-selling drugs, such as Lipitor and Plavix, will no longer have a monopoly on these drug formulas, pharmaceutical stocks will be able to weather the loss of these patents, said two health-care analysts.
-
As the Aug. 2 deadline to raise the country's $14.3 trillion debt ceiling approaches, investors should expect a downgrade—although it will probably only have a minor impact, said Thomas Lee, JPMorgan's chief U.S. equity strategist.
-
As Netflix prepares to release its second-quarter earnings after the bell on Monday, one analyst told CNBC the company's Latin American expansion and subscription price hikes could boost its earnings outlook.
-
As many companies are releasing their second-quarter earnings reports, one investment firm has released its list of top stock picks for the third quarter. David Kestenbaum, Morgan Joseph TriArtisan's head of equity research, detailed his top picks in an interview with CNBC on Friday.
-
As part of a preliminary investigation into the growing News Corp. phone-hacking scandal, the U.S. Department of Justice is preparing subpoenas of the media company relating to its alleged hacking of voicemail of Sept. 11 victims and foreign bribery, according to the Wall Street Journal.
-
The health-care plan passed in March 2010 will not be what is ultimately implemented, according to former Aetna CEO Ronald Williams.
-
In a rumored deal that could be one of the biggest buyouts since the financial crisis, Blackstone Group is said to be in talks to buy Kinetic Concepts, according to a report from the Dow Jones News Service.
-
As oil drops to its lowest price in four months, a former president of Shell USA Operations cautions that this decrease is the "pause that refreshes" and that oil will increase again due to a pick up in demand and an insufficient supply to meet it.
-
One of several tech companies to issue IPOs recently, Boingo Wireless had seen its stock drop almost 40 percent since its May 4 debut on the NASDAQ this morning.
-
A new test developed by a unit of biotech company Life Technologies has shown success in quickly pinpointing the strain of E. coli involved in a European outbreak that has killed 25 people and sickened more than 2,400 worldwide.
Featured
-
Thee retailer is soft-launching some of its home shops, which CEO Ron Johnson had called "pivotal" to its turnaround.
-
We're out to find the most-loved beer label. Round one votes are final. Cast your vote for the next!
-
Last year was a tough one for JC Penney, and now CEO Ron Johnson and other C-suiters are feeling the hit in their paychecks.
-
We're out to find the most-loved beer label in a March Madness-inspired contest. Check the first day's results and cast your vote!
More From Consumer Nation
-
Christina Cheddar Berk is editor of CNBC.com's Consumer Nation and chief trend spotter.
Retail
-
Thee retailer is soft-launching some of its home shops, which CEO Ron Johnson had called "pivotal" to its turnaround.
-
Retail lost 24,000 jobs in March. What can be done to encourage job growth and investment in the sector? Stacey Widlitz, S.W. Retail Advisors president, discusses. Also, CNBC's Courtney Reagan reports on whether JC Penney's turnaround strategy will work for the retailer.
-
Walmart has cut so many employees that it no longer can stock its food shelves properly, critics tell the NY Times.
